VENITI is a medical device company developing a suite of innovative technology and solutions that will provide comprehensive treatment across the venous disease continuum. Acquired by Boston Scientific for $160 million in August 2018.

For more information, visit Veniti or follow their updates on:

Veniti Articles

Veniti to be Bought in $160 Million Deal


Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

Veniti’s CFO Catherine Matthes on Clinical Trial Funding

How St. Louis Startup Pulse Therapeutics Attracted Success